If this were the only thing holding tL approval back, FDA would not have sent separate deficiency letter on tL in Jan.
Timing doesn't fit this theory: Teva announced it has received the Minor Deficiency letter on January 25th, 2011. Teva has disclosed it received the warning letter regarding its Jerusalem manufacturing facility on January 31st.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.